Search

Search Constraints

You searched for: Author/Creator Hasanov, Elshad

Search Results

1. 441 Outcomes of patients with metastatic renal cell carcinoma with intermediate- or poor-risk symptomatic disease who received their first cycle of nivolumab and ipilimumab while being hospitalized. (9th November 2020)

2. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. (16th June 2022)

6. Outcomes of patients with intermediate‐risk or poor‐risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience. Issue 2 (24th March 2021)

8. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. (March 2022)